Christian Berg
Automation Manager, Manufacturing Execution Systems
GENENTECH
Christian will be one of the distinguished speakers at the 2nd Annual Pharmaceutical Manufacturing Execution Systems Conference.
Why is the 2nd Annual Manufacturing Execution Systems Conference important to manufacturing teams?
Application of MES to pharmaceutical manufacturing is rapidly evolving. This conference creates a great environment to share best practices and build a community of experts to help leverage MES to drive down cost of cGMP production while maximizing quality.
How has MES evolved in the last several years?
Integration with control systems, monitoring systems, and enterprise management systems is becoming more critical as we seek to apply a better understanding of our manufacturing processes in order to improve process performance.
What initiatives are on the horizon at your organization in 2017?
System lifecycle management and implementation of new interfaces to enterprise systems will be the focus of our team in 2017.
How do you see MES evolving over the next 5-10 years?
Identifying and standardizing MES best practices for the pharma industry will be critical to reducing total cost of ownership for MES and to helping us keep up with regulatory expectations and dynamic production demands.
Why is this conference important to you as an industry leader?
MES is the “Central Nervous System” of our facility.
